Recurrent Cervical Carcinoma: Clinical Trials

2 trials for Recurrent Cervical Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1

Follow Recurrent Cervical Carcinoma: new trials by email Literature Review of Recurrent Cervical Carcinoma trials Research Report on Recurrent Cervical Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
the Re-irradiation of Recurrent Cervical Cancer by IMRT
intensity-modulated radiotherapy - Cervical Cancer, Radiation Toxicity
Not applicableUnknownSun Yat-sen University1082016-12-012018-09-10
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Palliative Therapy, Palliative Therapy + idiographic - Cervical Carcinoma, Ovarian Carcinoma
Not applicableCompletedAlbert Einstein College of Medicine952015-04-012019-09-17

Narrower conditions

Uterine Cervical Neoplasms (2)  ·  Ovarian Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Radiation Injuries (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Cervical Diseases (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Abdominal Neoplasms (1)  ·  Adnexal Diseases (1)  ·  Digestive System Diseases (1)

Interventions

Palliative Care (1)  ·  Radiotherapy, Intensity-Modulated (1)

Sponsors

Albert Einstein College of Medicine (1)  ·  Sun Yat-sen University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Nicole Nevadunsky (1)

NIH funding

P30CA013330 (1)